×
About 11,811 results

ALLMedicine™ Platelet Aggregation Center

Research & Reviews  5,783 results

Validation of an analytical method for the quantification of human fibrinogen in pharma...
https://doi.org/10.1007/s12185-020-03050-1 10.1021/ma902377g 10.1111/jth.14125 10.1016/j.cca.2011.02.029 10.1016/j.reuma.2012.09.002 10.1093/ndt/gfh1092 10.15171/apb.2015.068 10.1111/j.1538-7836.2008.03076.x 10.1111/j.1538-7836.2009.03633.x
International Journal of Hematology; Hernández-Longoria R, Hernández-Ruiz Y et. al.

Feb 26th, 2021 - Fibrinogen plays a vital role in normal homeostasis by promoting platelet aggregation, clot formation and fibrinolysis. It is quantified in finished pharmaceutical products using different methods described in pharmacopoeia, but these are inaccura...

Effect of ACG-1, an Extract Blend of Angelica gigas, Cynanchum wilfordii, and Ginkgo bi...
https://doi.org/10.1089/jmf.2020.4852
Journal of Medicinal Food; Jin H, Guo YR et. al.

Feb 22nd, 2021 - Thrombosis causes poor blood circulation, which may lead to several cardiovascular disorders. Antiplatelet aggregation and antihyperlipidemia are the key processes that improve blood circulation. The antiplatelet aggregation and antihyperlipidemic...

Comparison of the effect of Morphine and Fentanyl in patients with acute coronary syndr...
https://doi.org/10.1016/j.ijcard.2021.02.037
International Journal of Cardiology; Senguttuvan NB, Suman F et. al.

Feb 18th, 2021 - Dual antiplatelet therapy (DAPT) remains the cornerstone of acute coronary syndrome (ACS) management, and ticagrelor is one of the commonly used second antiplatelet agents. There is some evidence to suggest that morphine may reduce the antiplatele...

Loss of the exocyst complex component EXOC3 promotes hemostasis and accelerates arteria...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876885
Blood Advances; Walsh TG, Li Y et. al.

Feb 9th, 2021 - The exocyst is an octameric complex comprising 8 distinct protein subunits, exocyst complex components (EXOC) 1 to 8. It has an established role in tethering secretory vesicles to the plasma membrane, but its relevance to platelet granule secretio...

Impact of renin angiotensin system inhibitors on homocysteine levels and platelets reac...
https://doi.org/10.1016/j.numecd.2020.12.004
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Nardin M, Verdoia M et. al.

Feb 7th, 2021 - Dual antiplatelet therapy (DAPT) and Renin-angiotensin system inhibitors (RASi) represent the cornerstone in the treatment of patients undergoing percutaneous coronary interventions (PCI), mainly after an acute ischemic event. However, high-on tre...

see more →

Guidelines  1 results

Prophylaxis and management of venous thromboembolism in patients with myeloproliferativ...
https://doi.org/10.1007/s00277-014-2224-8
Annals of Hematology; Kreher S, Ochsenreither S et. al.

Oct 13th, 2014 - Patients with Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) like polycythemia vera and essential thrombocythemia are at increased risk of arterial and venous thrombosis. Strategies of prevention may consist of platelet aggreg...

see more →

Drugs  39 results see all →

Clinicaltrials.gov  5,887 results

Validation of an analytical method for the quantification of human fibrinogen in pharma...
https://doi.org/10.1007/s12185-020-03050-1 10.1021/ma902377g 10.1111/jth.14125 10.1016/j.cca.2011.02.029 10.1016/j.reuma.2012.09.002 10.1093/ndt/gfh1092 10.15171/apb.2015.068 10.1111/j.1538-7836.2008.03076.x 10.1111/j.1538-7836.2009.03633.x
International Journal of Hematology; Hernández-Longoria R, Hernández-Ruiz Y et. al.

Feb 26th, 2021 - Fibrinogen plays a vital role in normal homeostasis by promoting platelet aggregation, clot formation and fibrinolysis. It is quantified in finished pharmaceutical products using different methods described in pharmacopoeia, but these are inaccura...

Effect of ACG-1, an Extract Blend of Angelica gigas, Cynanchum wilfordii, and Ginkgo bi...
https://doi.org/10.1089/jmf.2020.4852
Journal of Medicinal Food; Jin H, Guo YR et. al.

Feb 22nd, 2021 - Thrombosis causes poor blood circulation, which may lead to several cardiovascular disorders. Antiplatelet aggregation and antihyperlipidemia are the key processes that improve blood circulation. The antiplatelet aggregation and antihyperlipidemic...

Comparison of the effect of Morphine and Fentanyl in patients with acute coronary syndr...
https://doi.org/10.1016/j.ijcard.2021.02.037
International Journal of Cardiology; Senguttuvan NB, Suman F et. al.

Feb 18th, 2021 - Dual antiplatelet therapy (DAPT) remains the cornerstone of acute coronary syndrome (ACS) management, and ticagrelor is one of the commonly used second antiplatelet agents. There is some evidence to suggest that morphine may reduce the antiplatele...

Loss of the exocyst complex component EXOC3 promotes hemostasis and accelerates arteria...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876885
Blood Advances; Walsh TG, Li Y et. al.

Feb 9th, 2021 - The exocyst is an octameric complex comprising 8 distinct protein subunits, exocyst complex components (EXOC) 1 to 8. It has an established role in tethering secretory vesicles to the plasma membrane, but its relevance to platelet granule secretio...

Impact of renin angiotensin system inhibitors on homocysteine levels and platelets reac...
https://doi.org/10.1016/j.numecd.2020.12.004
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Nardin M, Verdoia M et. al.

Feb 7th, 2021 - Dual antiplatelet therapy (DAPT) and Renin-angiotensin system inhibitors (RASi) represent the cornerstone in the treatment of patients undergoing percutaneous coronary interventions (PCI), mainly after an acute ischemic event. However, high-on tre...

see more →

News  101 results

Chewed Prasugrel for Primary PCI? Forget It!
https://www.medscape.com/viewarticle/933404

Jul 2nd, 2020 - Tirofiban is far superior to cangrelor at achieving rapid and potent inhibition of platelet aggregation in patients undergoing primary percutaneous coronary intervention for ST-elevation MI. And cangrelor, in turn, is superior to oral prasugrel, a...

Chewed Prasugrel for Primary PCI? Forget It!
https://www.staging.medscape.com/viewarticle/933404

Jul 2nd, 2020 - Tirofiban is far superior to cangrelor at achieving rapid and potent inhibition of platelet aggregation in patients undergoing primary percutaneous coronary intervention for ST-elevation MI. And cangrelor, in turn, is superior to oral prasugrel, a...

Clopidogrel Appropriate for PCI in Liver Transplant Candidates
https://www.medscape.com/viewarticle/923457

Jan 7th, 2020 - NEW YORK (Reuters Health) - In patients with decompensated cirrhosis undergoing percutaneous coronary intervention (PCI), clopidogrel safely inhibits platelet aggregation, according to a small study of liver-transplant candidates. "Patients with a...

Clopidogrel Appropriate for PCI in Liver Transplant Candidates
https://www.staging.medscape.com/viewarticle/923457

Jan 7th, 2020 - NEW YORK (Reuters Health) - In patients with decompensated cirrhosis undergoing percutaneous coronary intervention (PCI), clopidogrel safely inhibits platelet aggregation, according to a small study of liver-transplant candidates. "Patients with a...

Novel Antiplatelet Agent May Not Increase Bleeding Risk
https://www.staging.medscape.com/viewarticle/911977

Apr 17th, 2019 - A new approach to inhibiting platelets that may separate the antithrombotic effect from the bleeding risk has shown promising preliminary results, raising the hope of developing an agent for the treatment of acute ischemic stroke that can inhibit ...

see more →